These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 33617776)

  • 1. Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
    Sisa I; Noblecilla E; Orozco F
    Lancet; 2021 Mar; 397(10277):878. PubMed ID: 33617776
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccine research and the trouble with clinical equipoise.
    Friesen P; Caplan AL; Miller JE
    Lancet; 2021 Feb; 397(10274):576. PubMed ID: 33539728
    [No Abstract]   [Full Text] [Related]  

  • 3. Current COVID-19 vaccine trials in high-income countries: are placebo-controlled trials ethical?
    Dal-Ré R; Caplan AL
    Clin Microbiol Infect; 2021 Nov; 27(11):1565-1567. PubMed ID: 34375757
    [No Abstract]   [Full Text] [Related]  

  • 4. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    Rid A; Lipsitch M; Miller FG
    JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Equipoise in COVID-19 Vaccine Candidate Trials.
    Dal-Ré R
    J Clin Pharmacol; 2021 Sep; 61(9):1249-1250. PubMed ID: 33826784
    [No Abstract]   [Full Text] [Related]  

  • 6. Placebo-controlled trials with COVID-19 vaccines: participants first.
    Dal-Ré R
    J Clin Epidemiol; 2021 Oct; 138():211-212. PubMed ID: 34271109
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    Joffe S
    JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
    [No Abstract]   [Full Text] [Related]  

  • 8. "No" to placebo-controlled trials of Covid-19 vaccines.
    Ahmad A; Dhrolia MF
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trials for second generation Covid-19 vaccines: Revisiting the debate over placebo use in developing country clinical trials.
    Lurie P
    Indian J Med Ethics; 2021; VI(2):1-10. PubMed ID: 33908352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Dal-Ré R; Caplan AL; Gluud C; Porcher R
    Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccine trials: The use of active controls and non-inferiority studies.
    Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM
    Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccine equity and booster doses.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2021 Sep; 21(9):1193. PubMed ID: 34391506
    [No Abstract]   [Full Text] [Related]  

  • 13. Problematic Covid-19 vaccine trials in times of vaccine nationalism.
    Ravinetto R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A matter of priority: equitable access to COVID-19 vaccines.
    Holzer F; Luna F; Manriquez T; Biller-Andorno N
    Swiss Med Wkly; 2021 Mar; 151():w20488. PubMed ID: 33715145
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 vaccine inequity, dependency, and production capability in low-income and middle-income countries: the case of Bangladesh.
    Mahmud-Al-Rafat A; Hewins B; Mannan A; Kelvin DJ; Billah MM
    Lancet Infect Dis; 2022 Mar; 22(3):310-312. PubMed ID: 35101243
    [No Abstract]   [Full Text] [Related]  

  • 16. Placebo in new Covid-19 vaccine trials: data quality prioritised over participants' rights.
    Srinivasan S
    Indian J Med Ethics; 2021; VI(2):1-6. PubMed ID: 33908351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novavax's fridge-friendly vaccine impresses.
    Nat Biotechnol; 2021 Jul; 39(7):784. PubMed ID: 34257459
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethics of Placebo Control in Trials for Idiopathic Sudden Sensorineural Hearing Loss: Counterpoint.
    Shuman AG
    Otolaryngol Head Neck Surg; 2016 Jul; 155(1):13-4. PubMed ID: 27371620
    [No Abstract]   [Full Text] [Related]  

  • 19. US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
    Dal-Ré R
    Vaccine; 2021 Feb; 39(8):1180-1182. PubMed ID: 33516602
    [No Abstract]   [Full Text] [Related]  

  • 20. Placebo-controlled trials of Covid-19 vaccines - Are they still ethical?
    Ortiz-Millán G
    Indian J Med Ethics; 2021; VI(2):1-8. PubMed ID: 33908358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.